A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Approach Summary Licensing status Publication and contact information Drug delivery Malarial vaccine based on an adenoviral vector containing a B cell epitope An adenoviral vector expressing a B cell epitope could increase the immunogenicity of a malaria vaccine. In a mouse model of malaria, immunization with an adenoviral vector containing a B cell epitope of Plasmodium yoelii circumsporozoite (CS) protein increased antibody and T cell responses and reduced parasite burden in the liver anddoi:10.1038/scibx.2010.1107 fatcat:7zaqt4gzd5eotesyz62qrqvkry